Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Tianjiang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of concentrated Traditional Chinese Medicine (TCM) formula granules. Founded in 1992, it was the first enterprise in China to receive state approval for the pilot production of TCM granules and has played a pivotal role in standardizing TCM extracts. The company operates as a core subsidiary of China Traditional Chinese Medicine Holdings (China TCM), which is part of the Sinopharm group. Tianjiang's products are used extensively in hospitals and clinics across China and are exported to over 30 countries, providing a modern, standardized alternative to traditional herbal decoctions. The company maintains rigorous quality control through advanced technologies like fingerprint chromatography and is a key contributor to international standards for TCM.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjiang Pharmacy.